← Back to Search

Educational Materials for COVID-19 Vaccination During Pregnancy

N/A
Waitlist Available
Research Sponsored by University of Rochester
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Sex is female
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 month baseline compared to 6 month intervention
Awards & highlights

Study Summary

This trial will test whether sending educational materials to obstetrician's offices about the benefits of the COVID-19 vaccine for pregnant women will increase the number of pregnant women who get vaccinated.

Who is the study for?
This trial is for pregnant individuals who are eligible for the COVID-19 vaccine and have not yet received it. Participants must be female and currently affiliated with the participating OB/GYN sites, either as a provider, nurse, or staff member.Check my eligibility
What is being tested?
The study aims to increase maternal COVID-19 vaccination rates through a new intervention called VAX-MOM COVID-19 compared to standard care. It's a randomized controlled trial focusing on changing practices in obstetricians' offices.See study design
What are the potential side effects?
While specific side effects are not detailed here, common reactions to COVID-19 vaccines may include soreness at injection site, tiredness, headache, muscle pain, chills, fever, and nausea.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am female.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 month baseline compared to 6 month intervention
This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 month baseline compared to 6 month intervention for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Rate of COVID-19 vaccination

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: VAX-MOM COVID-19 InterventionExperimental Treatment1 Intervention
Group II: Standard of CareActive Control1 Intervention

Find a Location

Who is running the clinical trial?

University of RochesterLead Sponsor
845 Previous Clinical Trials
527,017 Total Patients Enrolled
4 Trials studying COVID-19
1,972 Patients Enrolled for COVID-19
Centers for Disease Control and PreventionFED
877 Previous Clinical Trials
22,470,204 Total Patients Enrolled
16 Trials studying COVID-19
100,813 Patients Enrolled for COVID-19
University of California, Los AngelesOTHER
1,538 Previous Clinical Trials
10,259,031 Total Patients Enrolled
21 Trials studying COVID-19
865,075 Patients Enrolled for COVID-19
~400 spots leftby Jul 2024
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top